Cyclerion Therapeutics In...

NASDAQ: CYCN · Real-Time Price · USD
3.17
0.04 (1.28%)
At close: Jun 05, 2025, 3:59 PM
3.24
2.21%
Pre-market: Jun 06, 2025, 09:13 AM EDT

Cyclerion Therapeutics Revenue Breakdown

Period Ending Dec 31, 2024
License Agreement Revenue 1.75M
License Agreement Revenue Growth n/a
License Revenue 250K
License Revenue Growth n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017
Selling, General, and Administrative Revenue 1.5M 1.25M 1.24M 1.28M 1.57M 1.77M 2.13M 3.36M 3.27M 3.51M 3.52M 3.52M 3.95M 4.41M 4.6M 6.24M 5.37M 7.26M 8.03M 6.63M 6.89M 7.38M 7.12M 8.92M 10.98M 8.45M 7.79M 7.53M 3.77M 2.92M 4.04M
Selling, General, and Administrative Revenue Growth +20.35% +0.56% -2.97% -18.74% -11.12% -16.89% -36.52% +2.69% -6.76% -0.54% +0.11% -10.91% -10.45% -4.09% -26.28% +16.33% -26.15% -9.56% +21.22% -3.83% -6.69% +3.74% -20.22% -18.71% +29.91% +8.51% +3.41% +99.79% +29.21% -27.74% n/a
Research and Development Revenue 36K 56K 81K 105K 44K 24K 580K 886K 3.77M 4.45M 7.08M 10.22M 9.74M 10.46M 7.03M 12.05M 8.09M 12.09M 13.7M 13.79M 16.82M 20.68M 22.3M 25.76M 26.4M 22.45M 21.5M 22.25M 21.51M 24.37M 20.83M
Research and Development Revenue Growth -35.71% -30.86% -22.86% +138.64% +83.33% -95.86% -34.54% -76.52% -15.21% -37.16% -30.69% +4.88% -6.84% +48.72% -41.66% +48.96% -33.08% -11.76% -0.66% -18.01% -18.65% -7.23% -13.45% -2.44% +17.60% +4.43% -3.38% +3.43% -11.72% +16.97% n/a